Kestra Advisory Services’s DermTech, Inc. Common Stock DMTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-13,725
Closed -$9.63K 2704
2024
Q1
$9.63K Buy
+13,725
New +$15.5K ﹤0.01% 2442
2023
Q1
Sell
-11,997
Closed -$21.2K 2337
2022
Q4
$21.2K Buy
11,997
+1,484
+14% +$3.95K ﹤0.01% 2215
2022
Q3
$42K Buy
10,513
+275
+3% +$1.69K ﹤0.01% 2038
2022
Q2
$57K Buy
+10,238
New +$83.8K ﹤0.01% 2032

Other funds holding DMTK

Kestra Advisory Services's DMTK Position: Q2 2024 in Review

Kestra Advisory Services sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2024, closing a stake of 13,725 shares — an estimated $9.63K sold.

Kestra Advisory Services first reported a position in DMTK in Q2 2022 and held it in 4 quarters. The position peaked at $57K in Q2 2022. 8 funds tracked by Wall St. Rank hold DMTK as of Q2 2024.

  • Kestra Advisory Services reported no remaining DermTech, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Kestra Advisory Services sold 13,725 DermTech, Inc. Common Stock shares in Q2 2024, an estimated $9.63K.
  • Kestra Advisory Services first reported a position in DermTech, Inc. Common Stock in Q2 2022 and held it in 4 quarters.
  • Kestra Advisory Services's DermTech, Inc. Common Stock position peaked at $57K in Q2 2022.
  • 8 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2024.

Based on Kestra Advisory Services's 13F filing for Q2 2024, filed 14 Aug 2024.